Agenus reported U$1 million in Ordinary Share Capital for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Abbvie U$ 18M 0M
Agenus U$ 1.714M 0.081M
Amgen U$ 31610M 85M
AstraZeneca 328M 0M
Bristol Myers Squibb U$ 292M 0M
Eli Lilly And U$ 598.1M 0M
Genocea Biosciences U$ 0.03M 0.002M
Gilead Sciences U$ 1M 0M
GlaxoSmithKline 1346M 0M
Glaxosmithkline U$ 1346M 0M
Merck € 168M 0M
Merk U$ 1788M 0M
Pfizer U$ 470M 0M
Regeneron Pharmaceuticals U$ 0.1M 0M
Veracyte U$ 0.05M 0M
YTE U$ 0.218M 0.001M